Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
Conditions: Systemic Sclerosis; Scleroderma Interventions: Biological: Anifrolumab (blinded); Drug: Placebo (blinded); Biological: Anifrolumab (unblinded, open label) Sponsor: AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials